Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Expert Review of Molecular Diagnostics|June 11, 2014
Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatmentChiara Camisaschi, Viviana Vallacchi, Chiara Castelli, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Heat shock proteins gp96 as immunogens in cancer patientsGiorgio Parmiani, Annamaria De Filippo, Lorenzo Pilla, et al.
Cancer Research|April 6, 2007
Tumor-released microvesicles as vehicles of immunosuppressionRoberta Valenti, Veronica Huber, Manuela Iero, et al.
Expert Opinion on Biological Therapy|July 14, 2009
Multipeptide vaccination in cancer patientsLorenzo Pilla, Licia Rivoltini, Roberto Patuzzo, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2014
Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapiesChiara Castelli, Licia Rivoltini, Monica Rodolfo, et al.
Cancer Treatment Reviews|March 26, 2018
Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needsStefano Cavalieri, Licia Rivoltini, Cristiana Bergamini, et al.
Oncoimmunology|March 14, 2013
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitorsMatteo Bellone, Arianna Calcinotto, Paola Filipazzi, et al.
International Journal of Colorectal Disease|October 1, 2022
Pathologic complete response after neoadjuvant chemotherapy/(re)chemoradiation for pelvic relapse of rectal cancer undergoing complex pelvic surgery: more frequent than expected?Luca Sorrentino, Elena Daveri, Giovanna Sabella, et al.
Cancers|August 7, 2021
Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against CancerFrancesco Mainini, Francesca De Santis, Giovanni Fucà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patientsCristina Maccalli, Daisuke Nonaka, Adriano Piris, et al.
Pageof 15